A number of cases have been performed with the Bioretec RemeOs trauma screw during controlled U.S. launch. Follow-up results confirmed that successful implantation and fracture healing were achieved in all cases. Surgeons reported no change to existing surgical technique while operating with an absorbable metal implant for their patients. The added benefit of osteopromotion and bioactivity on the fracture healing site was also reported to be a factor in the surgeon’s choice to use RemeOs screws in these procedures.
Bioretec is developing the line based on a magnesium alloy and hybrid composite. The RemeOs™ implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing.
“The controlled launch of the RemeOs trauma screw in the United States has progressed very much in line with our expectations. In my short tenure with Bioretec, these excellent results and surgeon feedback have given me confidence in our plans to increase our commercialization efforts in the U.S.”, says Alan Donze, CEO of Bioretec.
A number of cases have been performed with the Bioretec RemeOs trauma screw during controlled U.S. launch. Follow-up results confirmed that successful implantation and fracture healing were achieved in all cases. Surgeons reported no change to existing surgical technique while operating with an absorbable metal implant for their patients. The...
A number of cases have been performed with the Bioretec RemeOs trauma screw during controlled U.S. launch. Follow-up results confirmed that successful implantation and fracture healing were achieved in all cases. Surgeons reported no change to existing surgical technique while operating with an absorbable metal implant for their patients. The added benefit of osteopromotion and bioactivity on the fracture healing site was also reported to be a factor in the surgeon’s choice to use RemeOs screws in these procedures.
Bioretec is developing the line based on a magnesium alloy and hybrid composite. The RemeOs™ implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing.
“The controlled launch of the RemeOs trauma screw in the United States has progressed very much in line with our expectations. In my short tenure with Bioretec, these excellent results and surgeon feedback have given me confidence in our plans to increase our commercialization efforts in the U.S.”, says Alan Donze, CEO of Bioretec.
Copy to clipboard 
